Scarica l'app Stockscreener
6.68
13.80%
0.81
Armata Pharmaceuticals Inc Borsa (ARMP) Ultime notizie
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Coverage Initiated by Analysts at Jones Trading - Defense World
Jones Trading Initiates Coverage on Armata Pharmaceuticals (ARMP - GuruFocus
Jones Trading Initiates Coverage on Armata Pharmaceuticals (NYSEAMERICAN:ARMP) - MarketBeat
Jones Trading initiates coverage on Armata Pharmaceuticals stock with Buy rating - Investing.com Canada
Published on: 2026-01-05 08:37:29 - moha.gov.vn
Gap Down: Will Armata Pharmaceuticals Inc stock maintain dividend yieldMarket Growth Report & Risk Controlled Stock Pick Alerts - moha.gov.vn
Day Trade: Is Armata Pharmaceuticals Inc stock among top earnings playsLayoff News & Fast Exit and Entry Strategy Plans - moha.gov.vn
Will Armata Pharmaceuticals Inc stock maintain dividend yieldMarket Risk Summary & Growth Focused Entry Reports - moha.gov.vn
Pharma News: Will Armata Pharmaceuticals Inc stock gain from lower inflation2025 Market WrapUp & Real-Time Buy Signal Alerts - moha.gov.vn
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Trading 2.7% HigherStill a Buy? - MarketBeat
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Trading 2.7% Higher – Still a Buy? - Defense World
Aug Closing: Will Armata Pharmaceuticals Inc TG1N stock benefit from sector leadershipJuly 2025 Fed Impact & Consistent Growth Equity Picks - moha.gov.vn
Is Armata Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Price Swings & Fast Moving Market Watchlists - DonanımHaber
Can Armata Pharmaceuticals Inc. stock deliver surprise earnings beatDip Buying & Safe Capital Growth Tips - Улправда
Can Armata Pharmaceuticals Inc. (TG1N) stock sustain double digit ROEJuly 2025 Catalysts & Accurate Entry/Exit Alerts - Улправда
Why Armata Pharmaceuticals Inc. stock attracts global investorsWeekly Profit Recap & Long-Term Growth Portfolio Plans - Улправда
Armata Pharmaceuticals Earnings Notes - Trefis
Will Armata Pharmaceuticals Inc. stock pay special dividendsMarket Volume Summary & Low Risk High Win Rate Stock Picks - Улправда
Why Armata Pharmaceuticals Inc. stock attracts wealthy investors2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - Улправда
Will Armata Pharmaceuticals Inc. stock outperform energy sector in 2025July 2025 Setups & Advanced Technical Signal Analysis - Улправда
How Armata Pharmaceuticals Inc. stock reacts to bond yields2025 Volume Leaders & High Yield Equity Trading Tips - bolumsonucanavari.com
Will Armata Pharmaceuticals Inc. stock maintain dividend yieldJuly 2025 Setups & Smart Investment Allocation Tips - DonanımHaber
Is Armata Pharmaceuticals Inc. stock dividend growth reliableShare Buyback & Stepwise Trade Signal Implementation - DonanımHaber
Merger Talk: Can Armata Pharmaceuticals Inc. stock attract ESG capital inflowsWeekly Trade Review & Long-Term Growth Stock Strategies - DonanımHaber
Published on: 2025-12-19 11:47:18 - DonanımHaber
Will Armata Pharmaceuticals Inc. stock continue dividend increasesQuarterly Performance Summary & Verified Technical Signals - DonanımHaber
Can Armata Pharmaceuticals Inc. stock sustain revenue growth2025 Top Gainers & Safe Entry Trade Signal Reports - Улправда
Why Armata Pharmaceuticals Inc. (TG1N) stock is upgraded to buyCEO Change & AI Driven Stock Price Forecasts - Улправда
New Strong Sell Stocks for May 8th - sharewise.com
Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year? - MSN
Free cash flow per share of Armata Pharmaceuticals, Inc. – LS:A2PKLC - TradingView
Why Armata Pharmaceuticals Inc. (TG1N) stock benefits from AI revolution2025 Big Picture & AI Forecasted Stock Moves - Newser
Is Armata Pharmaceuticals Inc. (TG1N) stock testing key supportJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - Newser
Why Armata Pharmaceuticals Inc. (TG1N) stock attracts HNW investorsPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser
Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains? - MSN
Will Armata Pharmaceuticals Inc. stock announce special dividendBull Run & Real-Time Chart Breakout Alerts - Newser
Why Armata Pharmaceuticals Inc. stock is a strong buy call2025 Trade Ideas & Consistent Growth Equity Picks - Newser
Will Armata Pharmaceuticals Inc. stock split attract more investorsJuly 2025 Patterns & Weekly Top Stock Performers List - Newser
What is the fair value estimate for Armata Pharmaceuticals Inc. stock in 2025CPI Data & Long-Term Growth Plans - Newser
Will Armata Pharmaceuticals Inc. (TG1N) stock extend growth storyEarnings Risk Summary & Long-Term Safe Return Strategies - Newser
How Armata Pharmaceuticals Inc. (TG1N) stock compares with market leadersJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser
Is Armata Pharmaceuticals Inc. stock considered safe havenMarket Movement Recap & Accurate Entry and Exit Point Alerts - Newser
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Shares Up 12.8%Still a Buy? - MarketBeat
Market Catalysts: Can Armata Pharmaceuticals Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Safe Entry Trade Reports - BỘ NỘI VỤ
Will Armata Pharmaceuticals Inc. (TG1N) stock see insider accumulationQuarterly Portfolio Report & Smart Swing Trading Techniques - Newser
How risky is Armata Pharmaceuticals Inc. stock compared to peers2025 Trade Ideas & Real-Time Volume Analysis Alerts - Newser
Will Armata Pharmaceuticals Inc. (TG1N) stock sustain dividend payoutsWeekly Trend Report & AI Based Trade Execution Alerts - Newser
Is Armata Pharmaceuticals Inc. (TG1N) stock among top earnings playsEarnings Risk Report & Fast Momentum Entry Tips - Newser
How Armata Pharmaceuticals Inc. (TG1N) stock performs during market turbulenceJuly 2025 Gainers & Safe Capital Growth Stock Tips - Newser
Why analysts recommend Armata Pharmaceuticals Inc. stockDividend Hike & Daily Entry Point Trade Alerts - Newser
Is Armata Pharmaceuticals Inc. stock a buy before earnings resultsAnalyst Downgrade & Weekly Watchlist for Hot Stocks - Newser
Armata Pharmaceuticals Enters Capital Sales Agreement - TipRanks
28.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):